Microbiology
Showing page 122 of 252 pages of list content
-
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
This article's authors -
Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants
This article's authors -
Effect of nebulised BromAc ® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19
This article's authors -
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
This article's authors -
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
This article's authors -
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
This article's authors -
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
This article's authors -
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
This article's authors -
Super-immunity by broadly protective nanobodies to sarbecoviruses
This article's authors -
Improved binding affinity of the Omicron’s spike protein with hACE2 receptor is the key factor behind its increased virulence
This article's authors